Subsequently, we screened their reactivity with peripheral blood mononuclear cells (PBMCs) of COVID-19 patients with moderate or severe disease, as well as healthy donors (HDs), by measuring IFN-γ and IL-17A production. This evidence concerns the gene IL17A and COVID-19.